HUP0300755A2 - Heparinszármazék poliszacharid keverékek, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények - Google Patents

Heparinszármazék poliszacharid keverékek, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0300755A2
HUP0300755A2 HU0300755A HUP0300755A HUP0300755A2 HU P0300755 A2 HUP0300755 A2 HU P0300755A2 HU 0300755 A HU0300755 A HU 0300755A HU P0300755 A HUP0300755 A HU P0300755A HU P0300755 A2 HUP0300755 A2 HU P0300755A2
Authority
HU
Hungary
Prior art keywords
heparin
preparation
pharmaceutical compositions
compositions containing
containing same
Prior art date
Application number
HU0300755A
Other languages
English (en)
Inventor
Jacques Diaz
Christelle Pecquet
Elisabeth Perrin
Christian Viskov
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8852768&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0300755(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of HUP0300755A2 publication Critical patent/HUP0300755A2/hu
Publication of HUP0300755A3 publication Critical patent/HUP0300755A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

A találmány tárgyát a heparinszármazék poliszacharid keverékek,előállítási eljárásuk és ezeket tartalmazó gyógyszerkészítményekképezik. Ó
HU0300755A 2000-07-21 2001-07-18 Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same HUP0300755A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0009572A FR2811992B1 (fr) 2000-07-21 2000-07-21 Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
PCT/FR2001/002332 WO2002008295A1 (fr) 2000-07-21 2001-07-18 Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
HUP0300755A2 true HUP0300755A2 (hu) 2003-12-29
HUP0300755A3 HUP0300755A3 (en) 2004-03-01

Family

ID=8852768

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300755A HUP0300755A3 (en) 2000-07-21 2001-07-18 Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same

Country Status (36)

Country Link
EP (1) EP1307491B2 (hu)
JP (1) JP5279160B2 (hu)
KR (1) KR100853585B1 (hu)
CN (1) CN1230449C (hu)
AP (1) AP1703A (hu)
AR (1) AR029865A1 (hu)
AT (1) ATE470679T1 (hu)
AU (2) AU2001277602B2 (hu)
BR (1) BR0112612B1 (hu)
CA (1) CA2416673C (hu)
CL (1) CL2004001154A1 (hu)
CY (1) CY1110774T1 (hu)
DE (1) DE60142340D1 (hu)
DK (1) DK1307491T3 (hu)
DZ (1) DZ3411A1 (hu)
EA (1) EA005995B1 (hu)
EC (1) ECSP034442A (hu)
ES (1) ES2347134T5 (hu)
FR (1) FR2811992B1 (hu)
HK (1) HK1059273A1 (hu)
HR (1) HRP20030019A2 (hu)
HU (1) HUP0300755A3 (hu)
IL (2) IL153922A0 (hu)
MA (1) MA26928A1 (hu)
MX (1) MXPA03000579A (hu)
NO (1) NO20030296L (hu)
NZ (1) NZ524028A (hu)
OA (1) OA12340A (hu)
PL (1) PL202471B1 (hu)
PT (1) PT1307491E (hu)
SI (1) SI1307491T1 (hu)
TW (1) TWI307278B (hu)
UA (1) UA74836C2 (hu)
WO (1) WO2002008295A1 (hu)
YU (1) YU2903A (hu)
ZA (1) ZA200300898B (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6969705B2 (en) 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
ATE356150T1 (de) * 2002-06-20 2007-03-15 Chemi Spa Verfahren zur herstellung von heparinestern
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
AR041555A1 (es) 2002-10-10 2005-05-18 Aventis Pharma Sa Mezclas de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US7956046B2 (en) * 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
DE102004059134B4 (de) 2004-12-08 2011-12-15 Siemens Ag Expansionsvorrichtung für ein Röntgengerät und Röntgenstrahler
CA2652205A1 (en) * 2006-05-25 2007-12-06 Mallik Sundaram Low molecular weight heparin composition and uses thereof
CN101824099B (zh) * 2010-02-12 2011-11-30 淮安麦德森化学有限公司 一种粗品肝素钠的纯化方法
CN101824446B (zh) * 2010-02-24 2012-12-12 淮安麦德森化学有限公司 反向沉淀生产硫酸软骨素的方法
EP2399590A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for the prevention of a mortality and/or morbidity event in a patient undergoing major orthopaedic surgery
EP2399592A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in hip replacement surgery with improved safety in terms of clinically relevant bleedings and major bleedings
EP2399591A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for the extended prevention of a mortality and/or morbidity event in a patient having undergone hip fracture surgery
EP2399593A1 (en) 2010-06-28 2011-12-28 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in orthopaedic surgery with improved benefit-risk profile
CN102399379B (zh) * 2010-09-09 2016-08-31 上海喜恩医药科技发展有限公司 一种肝素衍生的多糖混合物及其制备方法和药物组合物
DK3144325T3 (da) * 2010-09-14 2021-01-25 Univ Miyazaki Heparin med høj renhed og fremstillingsfremgangsmåde dertil
WO2012055843A1 (en) 2010-10-28 2012-05-03 Aventis Pharma S.A. Semuloparin for the prevention of major venous thromboembolism in a patient undergoing major abdominal surgery
EP2446891A1 (en) 2010-10-28 2012-05-02 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in major abdominal surgery with improved safety in terms of clinically relevant bleedings and major bleedings
EP2548561A1 (en) 2011-07-22 2013-01-23 Aventis Pharma S.A. Semuloparin for improving the survival of patients with locally advanced cancer
ES2445494B1 (es) * 2012-08-02 2015-03-06 Rovi Lab Farmaceut Sa Procedimiento de obtención de heparinas de bajo y muy bajo peso molecular
CN103175925B (zh) * 2013-03-20 2014-12-03 山东辰中生物制药有限公司 依诺肝素钠生产过程中肝素苄基酯的酯化率的检测方法
FR3016632A1 (fr) * 2014-01-21 2015-07-24 IFP Energies Nouvelles Procede de transformation de polysaccharides en molecules oxygenees en presence de superbases organiques neutres
CZ306662B6 (cs) * 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
FR2482611B1 (fr) * 1980-05-14 1986-03-07 Pharmindustrie Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments
US4916219A (en) * 1985-03-28 1990-04-10 University Of Iowa Research Foundation Oligosaccharide heparin fragments as inhibitors of complement cascade
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
ES2077533B1 (es) * 1994-02-28 1996-07-01 Bioiberica Procedimiento de obtencion de fracciones de oligosacaridos por despolimerizacion quimica de heparina.
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
ES2161615B1 (es) * 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa Composiciones de heparinas de muy bajo peso molecular.

Also Published As

Publication number Publication date
AP2003002744A0 (en) 2003-03-31
AU7760201A (en) 2002-02-05
CY1110774T1 (el) 2015-06-10
EP1307491B1 (fr) 2010-06-09
DE60142340D1 (de) 2010-07-22
ATE470679T1 (de) 2010-06-15
BR0112612B1 (pt) 2011-07-12
KR20030040364A (ko) 2003-05-22
CA2416673A1 (fr) 2002-01-31
PT1307491E (pt) 2010-09-10
TWI307278B (en) 2009-03-11
WO2002008295A1 (fr) 2002-01-31
FR2811992A1 (fr) 2002-01-25
EA200300178A1 (ru) 2003-06-26
BR0112612A (pt) 2003-07-29
CL2004001154A1 (es) 2005-05-27
EP1307491A1 (fr) 2003-05-07
FR2811992B1 (fr) 2003-07-04
AU2001277602B2 (en) 2007-07-19
ES2347134T5 (es) 2014-06-24
PL202471B1 (pl) 2009-06-30
HRP20030019A2 (en) 2005-10-31
CN1447820A (zh) 2003-10-08
UA74836C2 (en) 2006-02-15
HUP0300755A3 (en) 2004-03-01
CN1230449C (zh) 2005-12-07
EP1307491B2 (fr) 2014-05-07
SI1307491T1 (sl) 2010-10-29
MXPA03000579A (es) 2003-06-06
NO20030296D0 (no) 2003-01-20
ZA200300898B (en) 2004-04-30
MA26928A1 (fr) 2004-12-20
YU2903A (sh) 2006-03-03
AR029865A1 (es) 2003-07-16
HK1059273A1 (en) 2004-06-25
JP5279160B2 (ja) 2013-09-04
ES2347134T3 (es) 2010-10-26
NO20030296L (no) 2003-01-20
NZ524028A (en) 2004-12-24
PL365561A1 (en) 2005-01-10
DZ3411A1 (fr) 2002-01-31
CA2416673C (fr) 2011-06-14
DK1307491T3 (da) 2010-10-11
JP2004504451A (ja) 2004-02-12
IL153922A0 (en) 2003-07-31
IL153922A (en) 2010-05-17
AP1703A (en) 2007-02-26
OA12340A (fr) 2006-05-15
KR100853585B1 (ko) 2008-08-21
EA005995B1 (ru) 2005-08-25
ECSP034442A (es) 2003-03-10

Similar Documents

Publication Publication Date Title
HUP0300755A2 (hu) Heparinszármazék poliszacharid keverékek, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
NO20051427L (no) Fremgangsmate for produksjon av hydroksyalkyl stivelsesderivater
HUP0302874A2 (hu) Eljárás risperidon előállítására
NO20002788D0 (no) Nye forbindelser
ATE334662T1 (de) Herstellungsverfahren von arzneizubereitungen
IS4536A (is) Ný taxóíð, aðferð til framleiðslu þeirra og lyfjasamsetningar sem innihalda þau
NO20050090L (no) Fremgangsmate for fremstilling av et virus-inaktivert trombinpreparat
DK0991653T3 (da) Nye forbindelser
IS4635A (is) 4-fenýlamínóþíasólafleiður, aðferð við að framleiða þær og lyfjablöndur sem innihalda þær
FI980862A0 (fi) Kiraalisia metyylifenyylioksatsolidinoneja
NO20062605L (no) Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper
ATE231872T1 (de) Thiazolopyrimidinderivate
HUP0401592A2 (hu) Modafinilvegyület és ciklodextrin keverékek, eljárás az előállításukra és ezeket tartalmazó készítmények
EE05091B1 (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
AU2001277602A1 (en) Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same
IS1968B (is) Tilbúnar fjölsykrur, aðferð við að framleiða þær og lyfjablöndur sem innihalda þær
BR9807936A (pt) Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação
YU63696A (sh) Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
WO2003082895A3 (en) Process to prepare eplerenone
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
TR200402030T4 (tr) İkame edilen I-aminobutan-3-ol-türevleri
CY1112050T1 (el) Νεα 2-αλογονοποιημενα παραγωγα της 5-0- δεσοσαμινυλερυθρονολιδης α, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα
IS7008A (is) Nýjar píperidínkarboxamíð afleiður, aðferð til framleiðslu þeirra og lyfjasamsetningar sem innihalda þær
WO2001049651A3 (de) Aminomethyl-phenyl-cyclohexanonderivate

Legal Events

Date Code Title Description
FH91 Appointment of a representative

Free format text: FORMER REPRESENTATIVE(S): BELICZAY LASZLO, S.B.G. & K. SZABADALMI UEGYVIVOEI IRODA, HU

Representative=s name: DANUBIA SZABADALMI ES JOGI IRODA KFT., HU

FH92 Termination of representative

Representative=s name: BELICZAY LASZLO, S.B.G. & K. SZABADALMI UEGYVI, HU

FD9A Lapse of provisional protection due to non-payment of fees